Claudio Marasca (C Marasca)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 59

Top Topics

Hidradenitis Suppurativa

Top Venues

Journal of the European Academy of Dermatology and Venereology : JEADV

Dermatologic therapy

Clinical and experimental dermatology

International wound journal

This page only lists publications with an associated author ORCID identifier.

Publications

Giuseppe Monfrecola, Luigi Fornaro, Paolo Antonio Ascierto, Luigi Scarpato, Anna Maria Anniciello, Gabriella Fabbrocini, Claudio Marasca
Could wide tattoo delay the early diagnosis of cutaneous melanoma? Journal of the European Academy of Dermatology and Venereology : JEADV (2023)
Fabrizio Martora, Paolo Ascierto, Marco Palla, Claudia Costa, Mirella D'Andrea, Rossella Di Trolio, Luigi Scarpato, Claudio Marasca
Tirbanibulin:An alternative topical approach to manage superficial Basal Cell Carcinoma. Clinical and experimental dermatology (2023)
Fabrizio Martora, Claudio Marasca, Vincenzo Picone, Luigi Fornaro, Matteo Megna, Gabriella Fabbrocini
How Adalimumab Impacts Antibiotic Prescriptions in Patients Affected by Hidradenitis Suppurativa: A 1-Year Prospective Study and Retrospective Analysis. Journal of clinical medicine 12 (3) (2023)
Fabrizio Martora, Alessia Villani, Claudio Marasca, Gabriella Fabbrocini, Ruggiero Angelo
Cutaneous adverse reaction following COVID-19 vaccination: Report from a southern Italian referral centre. Comment on "cutaneous adverse reactions following the Pfizer/BioNTech COVID-19 vaccine" by Luo et al. The Australasian journal of dermatology (2023)
Giuseppe Monfrecola, Luigi Fornaro, Paolo Antonio Ascierto, Luigi Scarpato, Claudia Costa, Fabrizio Martora, Claudio Marasca
Comment on the relationship between wide tattoos and delayed melanoma diagnosis. Journal of the European Academy of Dermatology and Venereology : JEADV (2023)
Fabrizio Martora, Alessia Villani, Claudio Marasca, Gabriella Fabbrocini, Ruggiero Angelo
Cutaneous adverse reaction following COVID-19 vaccination: Report from a southern Italian referral centre. Comment on "cutaneous adverse reactions following the Pfizer/BioNTech COVID-19 vaccine" by Luo et al. The Australasian journal of dermatology 64 (1) (2023)
Fabrizio Martora, Gabriella Fabbrocini, Claudio Marasca, Teresa Battista, Matteo Megna
Paradoxical hidradenitis suppurativa induced by adalimumab biosimilar successfully treated with guselkumab in a psoriasis patient. Comment on "Paradoxical hidradenitis suppurativa due to anti-interleukin-1 agents for mevalonate kinase deficiency successfully treated with the addition of ustekinumab". Clinical and experimental dermatology (2023)
Fabrizio Martora, Claudio Marasca, Vincenzo Picone, Luigi Fornaro, Matteo Megna, Gabriella Fabbrocini
How Adalimumab Impacts Antibiotic Prescriptions in Patients Affected by Hidradenitis Suppurativa: A 1-Year Prospective Study and Retrospective Analysis. Journal of clinical medicine 12 (3) (2023)
Fabrizio Martora, Paolo Antonio Ascierto, Massimiliano Scalvenzi, Marco Palla, Claudia Costa, Mirella D'Andrea, Rossella Di Trolio, Luigi Scarpato, Claudio Marasca
Tirbanibulin ointment to manage recurrence of superficial Basal Cell Carcinoma of the face: report of a case. Clinical and experimental dermatology (2023)
Ruggiero Angelo, Claudio Marasca, Gabriella Fabbrocini, Massimo Mascolo, Vincenzo Greco
A unilateral slow-growing yellow nodule of the glans penis. Clinical and experimental dermatology 48 (1) (2023)
Fabrizio Martora, Alessia Villani, Claudio Marasca, Gabriella Fabbrocini, Ruggiero Angelo
Cutaneous adverse reaction following COVID-19 vaccination: Report from a southern Italian referral centre. Comment on "cutaneous adverse reactions following the Pfizer/BioNTech COVID-19 vaccine" by Luo et al. The Australasian journal of dermatology 64 (1) (2023)
Fabrizio Martora, Claudio Marasca, Vincenzo Picone, Luigi Fornaro, Matteo Megna, Gabriella Fabbrocini
How Adalimumab Impacts Antibiotic Prescriptions in Patients Affected by Hidradenitis Suppurativa: A 1-Year Prospective Study and Retrospective Analysis. Journal of clinical medicine 12 (3) (2023)
Fabrizio Martora, Alessia Villani, Claudio Marasca, Gabriella Fabbrocini, Ruggiero Angelo
Cutaneous adverse reaction following COVID-19 vaccination: Report from a southern Italian referral centre. Comment on "cutaneous adverse reactions following the Pfizer/BioNTech COVID-19 vaccine" by Luo et al. The Australasian journal of dermatology 64 (1) (2023)
Giuseppe Monfrecola, Luigi Fornaro, Paolo Antonio Ascierto, Luigi Scarpato, Anna Maria Anniciello, Gabriella Fabbrocini, Claudio Marasca
Could wide tattoo delay the early diagnosis of cutaneous melanoma? Journal of the European Academy of Dermatology and Venereology : JEADV (2023)
Fabrizio Martora, Claudio Marasca, Teresa Battista, Gabriella Fabbrocini, Ruggiero Angelo
Management of patients with hidradenitis suppurativa during COVID-19 vaccination: an experience from southern Italy. Comment on: 'Evaluating the safety and efficacy of COVID-19 vaccination in patients with hidradenitis suppurativa'. Clinical and experimental dermatology 47 (11) (2022)
Martina Burlando, Gabriella Fabbrocini, Claudio Marasca, Paolo Dapavo, Andrea Chiricozzi, Dalma Malvaso, Valentina Dini, Campanati Anna, Annamaria Offidani, Annunziata Dattola, Raffaele Dante Caposiena Caro, Luca Bianchi, Marina Venturini, Paolo Gisondi, Claudio Guarneri, Giovanna Malara, Caterina Trifirò, Piergiorigio Malagoli, Maria-Concetta Fargnoli, Stefano Piaserico, Luca Carmisciano, Riccardo Castelli, Aurora Parodi
Adalimumab Originator vs. Biosimilar in Hidradenitis Suppurativa: A Multicentric Retrospective Study. Biomedicines 10 (10) (2022)
Luca Potestio, Luigi Fornaro, Fabrizio Martora, Vincenzo Picone, Gabriella Fabbrocini, Claudio Marasca
Reply to Borgia et al. Comment on "Marasca et al. Teledermatology and Inflammatory Skin Conditions during COVID-19 Era: New Perspectives and Applications. J. Clin. Med. 2022, 11 , 1511". Journal of clinical medicine 11 (14) (2022)
Ruggiero Angelo, Claudio Marasca, Alessia Villani, Gabriella Fabbrocini, Fabrizio Martora
Tacrolimus ointment may improve the effectiveness of adalimumab in patients with hidradenitis suppurativa: a novel promising treatment. Clinical and experimental dermatology 47 (10) (2022)
Ruggiero Angelo, Claudio Marasca, Gabriella Fabbrocini, Alessia Villani, Fabrizio Martora
Teledermatology in the management of hidradenitis suppurativa: Should we improve this service? Journal of cosmetic dermatology (2022)
Fabrizio Martora, G Fabbrocini, P Nappa, Claudio Marasca, C Patruno, M Scalvenzi, Maddalena Napolitano
Reply to 'A case of dystrophic epidermolysis bullosa pruriginosa treated with dupilumab' by Caroppo et al. Journal of the European Academy of Dermatology and Venereology : JEADV 36 (9) (2022)
Ruggiero Angelo, Fabrizio Martora, Vincenzo Picone, Laura Marano, Gabriella Fabbrocini, Claudio Marasca
Paradoxical Hidradenitis Suppurativa during Biologic Therapy, an Emerging Challenge: A Systematic Review. Biomedicines 10 (2) (2022)
Fabrizio Martora, Claudio Marasca, Gabriella Fabbrocini, Ruggiero Angelo
Strategies adopted in a southern Italian referral centre to reduce adalimumab discontinuation: comment on 'Can we increase the drug survival time of biologic therapies in hidradenitis suppurativa?' Clinical and experimental dermatology 47 (10) (2022)
Wanda Lauro, Gianmarco Capasso, Gabriella Fabbrocini, Claudio Marasca
Hair removal and deodorants in hidradenitis suppurativa: An online survey on patients' habits. Journal of cosmetic dermatology (2022)
Claudio Marasca, Maria Carmela Annunziata, Elisa Camela, Adriana Di Guida, Luigi Fornaro, Matteo Megna, Maddalena Napolitano, Cataldo Patruno, Luca Potestio, Gabriella Fabbrocini
Teledermatology and Inflammatory Skin Conditions during COVID-19 Era: New Perspectives and Applications. Journal of clinical medicine 11 (6) (2022)
Fabrizio Martora, Alessia Villani, Claudio Marasca, Gabriella Fabbrocini, Luca Potestio
Skin reaction after SARS-CoV-2 vaccines Reply to 'cutaneous adverse reactions following SARS-CoV-2 vaccine booster dose: A real-life multicentre experience'. Journal of the European Academy of Dermatology and Venereology : JEADV (2022)
Fabrizio Martora, Teresa Battista, Luigi Fornaro, Gabriella Fabbrocini, Matteo Megna, Vincenzo Picone, Claudio Marasca
Generalized versus localized vitiligo after ixekizumab: May previous treatment affect the clinical presentation? Dermatologic therapy (2022)
Luca Potestio, Lucia Genco, Alessia Villani, Claudio Marasca, G Fabbrocini, L Fornaro, Ruggiero Angelo, Fabrizio Martora
Reply to 'Cutaneous adverse effects of the available COVID-19 vaccines in India: A questionnaire-based study' by Bawane J et al. Journal of the European Academy of Dermatology and Venereology : JEADV 36 (11) (2022)
Adriana Di Guida, Patrizia Forgione, Luigi Fornaro, Dario Marasca, Gabriella Fabbrocini, Claudio Marasca
Step by step surgery for hidradenitis suppurativa. Dermatologic therapy (2022)
Fabrizio Martora, Vincenzo Picone, Teresa Battista, Gabriella Fabbrocini, Claudio Marasca
Reply to "the significance of investigating clinical, histopathologic and virological features in pityriasis rosea and pityriasis rosea-like eruptions following COVID-19 vaccinations" by Ciccarese G. et al. Dermatologic therapy 35 (8) (2022)
Simone Ribero, Alice Ramondetta, G Fabbrocini, Vincenzo Bettoli, C Potenza, A Chiricozzi, M Licciardello, Angelo Valerio Marzano, L Bianchi, G Rozzo, Luca Fania, Claudio Marasca, Giulia Odorici, A Mambrin, C Moltrasio, Raffaele Dante Caposiena Caro, N Skroza, Pietro Quaglino, N Siliquini, P Dapavo
Effectiveness of Secukinumab in the treatment of moderate-severe hidradenitis suppurativa: results from an Italian multicentric retrospective study in a real-life setting. Journal of the European Academy of Dermatology and Venereology : JEADV 35 (7) (2021)
F Nastro, G Fabbrocini, F di Vico, Claudio Marasca
Small vessel vasculitis related to varicella-zoster virus after Pfizer-BioNTech COVID-19 vaccine. Journal of the European Academy of Dermatology and Venereology : JEADV 35 (11) (2021)
Fabrizio Martora, Vincenzo Picone, Luigi Fornaro, Gabriella Fabbrocini, Claudio Marasca
Can COVID-19 cause atypical forms of pityriasis rosea refractory to conventional therapies? Journal of medical virology 94 (4) (2021)
Francesca Nastro, Ruggiero Angelo, Gustavo Spanò, Sara Cacciapuoti, Mariateresa Cantelli, Gabriella Fabbrocini, Claudio Marasca
Neoadjuvant use of methotrexate in eosinophilic angiocentric fibrosis of upper lip and hard palate: A case report. Dermatologic therapy 34 (5) (2021)
Fabrizio Martora, Gabriella Fabbrocini, Claudio Marasca
Pityriasis rosea after Moderna mRNA-1273 vaccine: A case series. Dermatologic therapy (2021)
Claudio Marasca, Luigi Fornaro, Fabrizio Martora, Vincenzo Picone, Gabriella Fabbrocini, Matteo Megna
Onset of vitiligo in a psoriasis patient on ixekizumab. Dermatologic therapy 34 (5) (2021)
Matteo Megna, Ruggiero Angelo, Adriana Di Guida, Angela Patrì, Gabriella Fabbrocini, Claudio Marasca
Ixekizumab: An efficacious treatment for both psoriasis and hidradenitis suppurativa. Dermatologic therapy 33 (4) (2020)
Claudio Marasca, Maddalena Napolitano, G Monfrecola, A Masarà, Maria Carmela Annunziata, Marianna Donnarumma, G Fabbrocini
Quality of life in people living with patients suffering from hidradenitis suppurativa. Journal of the European Academy of Dermatology and Venereology : JEADV 34 (7) (2020)
Ruggiero Angelo, Claudio Marasca, Sonia Sofia Ocampo-Garza, Gabriella Fabbrocini, Alessia Villani
SMS support group in the management of acne: A useful tool to increase adherence to treatment. Dermatologic therapy 34 (1) (2020)
Matteo Megna, Angelo Ruggiero, Elisa Camela, Gabriella Fabbrocini, Claudio Marasca
A case of erythrodermic psoriasis successfully treated with guselkumab. Dermatologic therapy 33 (2) (2020)
Claudio Marasca, D Marasca, Matteo Megna, Maria Carmela Annunziata, G Fabbrocini
Ultrasound: an indispensable tool to evaluate the outcome of surgical approaches in patients affected by hidradenitis suppurativa. Journal of the European Academy of Dermatology and Venereology : JEADV 34 (8) (2020)
Claudio Marasca, Gabriella Fabbrocini, Mirella D'Andrea, Maria Antonietta Luciano, Gabriele De Maio, Ruggiero Angelo
Low dose oral corticosteroids, microneedling, and topical 5-fluorouracil: A novel treatment for recalcitrant pediatric vitiligo. Pediatric dermatology 38 (1) (2020)
Orlando Zagaria, Ruggiero Angelo, Gabriella Fabbrocini, Lucia Gallo, Marco Romanelli, Claudio Marasca
Wound care, adalimumab, and multidisciplinary approach in a patient affected by PASH syndrome. International wound journal 17 (5) (2020)
Orlando Zagaria, Ruggiero Angelo, Eleonora Cinelli, Claudio Marasca, Ambra Monfrecola, Gabriella Fabbrocini
Chronic cutaneous ulcers management in dermatologic department during COVID-19 era. International wound journal 17 (5) (2020)
Claudio Marasca, Ruggiero Angelo, G Fontanella, Maria Ferrillo, G Fabbrocini, Alessia Villani
Telemedicine and support groups could be used to improve adherence to treatment and health-related quality of life in patients affected by inflammatory skin conditions during the COVID-19 pandemic. Clinical and experimental dermatology 45 (6) (2020)
G Fabbrocini, Claudio Marasca, Matteo Megna, K Peris, null null
Age and gender influence on HIDRAdisk outcomes in adalimumab-treated hidradenitis suppurativa patients. Journal of the European Academy of Dermatology and Venereology : JEADV (2020)
Matteo Megna, Gabriella Fabbrocini, Claudio Marasca
Chronic inflammatory skin diseases and biologics: what to expect after COVID-19 pandemic? International journal of dermatology 59 (9) (2020)
Marianna Donnarumma, Mariateresa Nocerino, Wanda Lauro, Maria Carmela Annunziata, Claudio Marasca, Gabriella Fabbrocini
Isotretinoin in acne treatment during the coronavirus disease 2019 (COVID-19): A retrospective analysis of adherence to therapy and side effects. Dermatologic therapy 34 (1) (2020)
Claudio Marasca, Ruggiero Angelo, Maria Carmela Annunziata, G Fabbrocini, Matteo Megna
Face the COVID-19 emergency: measures applied in an Italian Dermatologic Clinic. Journal of the European Academy of Dermatology and Venereology : JEADV 34 (6) (2020)
Matteo Megna, Claudio Marasca, Ruggiero Angelo, Elisa Camela, Gabriella Fabbrocini
Secukinumab: a potential safe option in psoriasis patients affected by multiple sclerosis? International journal of dermatology 59 (8) (2020)
Claudio Marasca, Gabriella Fabbrocini, Eleonora Cinelli, Giuseppina Fontanella, Dario Marasca, Orlando Zagaria
A case of a primary cutaneous diffuse large B-cell lymphoma, leg type. International wound journal 17 (2) (2019)
Claudio Marasca, Marianna Donnarumma, Maria Carmela Annunziata, G Fabbrocini
Comment on 'The effects of isotretinoin therapy on serum homocysteine, folate and vitamin B12 levels in patients with acne': may retinoids be useful to treat hyperhomocysteinemia found in patients affected by hidradenitis suppurativa? Journal of the European Academy of Dermatology and Venereology : JEADV 34 (3) (2019)
Claudio Marasca, E Scala, R Di Caprio, A Raimondo, S Cacciapuoti, Anna Balato, G Fabbrocini
Notch dysregulation and hidradenitis suppurativa, psoriasis, atopic dermatitis and lichen planus: let's talk about Numb. The British journal of dermatology 180 (4) (2019)
Claudio Marasca, Giuseppina Fontanella, Maria C Annunziata, Dario Marasca, Gabriella Fabbrocini
Adalimumab plus topical tacrolimus for the treatment of pyoderma gangrenosum: Report of a case. International wound journal 16 (4) (2019)
Claudio Marasca, Giuseppina Fontanella, Gabriella Fabbrocini, Gabriele De Maio, Paolo Tranchini, Eleonora Cinelli, Vincenzo Marino, Matteo Megna
A case of Stewart-Treves Syndrome of the lower limbs: The usefulness of dermoscopy. International wound journal 16 (5) (2019)
Claudio Marasca, A Masarà, Maria Carmela Annunziata, V Bettoli, M A Luciano, G Fabbrocini
Long-term clinical safety of clindamycin and rifampicin combination for the treatment of hidradenitis suppurativa: a strategy to reduce side-effects, improving patients' compliance. The British journal of dermatology 180 (4) (2019)
Luigi Barrea, Gabriella Fabbrocini, Giuseppe Annunziata, Giovanna Muscogiuri, Marianna Donnarumma, Claudio Marasca, Annamaria Colao, Silvia Savastano
Role of Nutrition and Adherence to the Mediterranean Diet in the Multidisciplinary Approach of Hidradenitis Suppurativa: Evaluation of Nutritional Status and Its Association with Severity of Disease. Nutrients 11 (1) (2018)
Claudio Marasca, M Donnarumma, Maria Carmela Annunziata, G Fabbrocini
Homocysteine plasma levels in patients affected by hidradenitis suppurativa: an Italian experience. Clinical and experimental dermatology 44 (3) (2018)
Claudio Marasca, M Mascolo, M Ferrillo, A Masarà, M C Annunziata, A Iacobelli, G Fabbrocini
Acitretin may improve symptoms and exudation in patients affected by elephantiasis nostras verrucosa: Report of a case. International wound journal 16 (2) (2018)
Claudio Marasca, A Balato, M C Annunziata, S Cacciapuoti, G Fabbrocini
Insulin resistance, mTOR and hidradenitis suppurativa. Journal of the European Academy of Dermatology and Venereology : JEADV 33 (3) (2018)